Abstract
Background The COVID-19 pandemic started a little later in Ethiopia than Europe and most of the initial cases were reported to have a milder disease course and a favorable outcome. This changed as the disease spread into the population and the more vulnerable began to develop severe disease. Understanding the risk factors for severe disease in Ethiopia was needed to provide optimal health care services in a resource limited setting.
Objective The study assessed COVID-19 patients admitted to Millennium COVID-19 Care Center in Ethiopia for characteristics associated with COVID-19 disease severity.
Methods A cross-sectional study was conducted from June to August 2020 among 686 randomly selected 686 patients. Chi-square test was used to detect the presence of a statistically significant difference in the characteristics of the patients based on disease severity (Mild vs Moderate vs Severe). A multinomial logistic regression model was used to identify risk factors of COVID-19 disease severity where Adjusted Odds ratio (AOR), 95% CIs for AOR and P-values were used for significance testing.
Results Having moderate as compared with mild disease was significantly associated with having hypertension (AOR=2.30, 95%CI=1.27,4.18, p-value=0.006), diabetes mellitus (AOR=2.61, 95%CI=1.31,5.19, p-value=0.007 for diabetes mellitus), fever (AOR=6.12, 95%CI=2.94,12.72, p-value=0.0001) and headache (AOR=2.69, 95%CI=1.39,5.22, p-value=0.003). Similarly, having severe disease as compared with mild disease was associated with age group (AOR=4.43, 95%CI=2.49,7.85, p-value=0.0001 for 40-59 years and AOR=18.07, 95%CI=9.29,35.14, p-value=0.0001 for ≥ 60 years), sex (AOR=1.84, 95%CI=1.12,3.03, p-value=0.016), hypertension (AOR=1.97, 95%CI=1.08,3.59, p-value=0.028), diabetes mellitus (AOR=3.93, 95%CI=1.96,7.85, p-value=0.0001), fever (AOR=13.22, 95%CI=6.11, 28.60, p-value=0.0001) and headache (AOR=4.82, 95%CI=2.32, 9.98, p-value=0.0001). In addition, risk factors of severe disease as compared with moderate disease were found to be significantly associated with age group (AOR=4.87, 95%CI=2.85, 8.32, p-value=0.0001 for 40-59 years and AOR=18.91, 95%CI=9.84,36.33, p-value=0.0001 for ≥ 60 years), fever (AOR=2.16, 95%CI=1.29,3.63, p-value=0.004) and headache (AOR=1.79, 95%CI=1.03, 3.11, p-value=0.039).
Conclusions Risk factors associated with severe COVID-19 in Ethiopia are being greater than 60 years old, male, a diagnosis of hypertension, and diabetes mellitus, and the presence of fever and headache. This is consistent with severity indicators identified by WHO and suggests the initial finding of milder disease in Ethiopia may have been because the first people to get COVID-19 in Ethiopia were less than 60 years of age with fewer health problems.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
St. Paul's Hospital Millennium Medical College Institutional Review Board
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are available upon reasonable request
List of Abbreviations
- CI
- Confidence Interval
- COVID-19
- Coronavirus Disease 2019
- FiO2
- Fraction of Inspired Oxygen
- LDH
- Lactate Dehydrogenase
- OR
- Odds Ratio
- PaO2
- Partial Pressure of Oxygen
- SARS-COV-2
- Severe Acute Respiratory Syndrome Coronavirus 2
- SpO2
- Saturation of Oxygen
- RT-PCR…
- Real Time Polymerase Chain Reaction
